175532-13-5

Basic information

• Product Name: BENZENEETHANIMIDAMIDE, 3-CHLORO-N-HYDROXY-
• Synonyms: BENZENEETHANIMIDAMIDE, 3-CHLORO-N-HYDROXY-;(Z)-2-(3-chlorophenyl)-N-hydroxyacetimidamide
• CAS NO: 175532-13-5
• Molecular Formula: C₈H₉ClN₂O
• Molecular Weight: 184.62
• Mol File: 175532-13-5.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: BENZENEETHANIMIDAMIDE, 3-CHLORO-N-HYDROXY-(CAS DataBase Reference)
• NIST Chemistry Reference: BENZENEETHANIMIDAMIDE, 3-CHLORO-N-HYDROXY-(175532-13-5)
• EPA Substance Registry System: BENZENEETHANIMIDAMIDE, 3-CHLORO-N-HYDROXY-(175532-13-5)

Safety Data

• Hazardous Substances Data: 175532-13-5(Hazardous Substances Data)

Upstream product

• 1529-41-5 3-chloro-benzeneacetonitrile 

Downstream Products

• 1443208-12-5 3-(3-chlorobenzyl)-5-(3-(piperidin-4-yloxy)benzo[b]thiophen-2-yl)-1,2,4-oxadiazole 
• 1146522-21-5 2-chloro-3-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]pyridine 
• 1146521-99-4 2-butoxy-3-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]pyridine 
• 1026616-08-9 (S)-1-[3-(3-Chloro-benzyl)-[1,2,4]oxadiazol-5-yl]-ethylamine 
• 128104-42-7 4-[(3-chlorophenyl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide 

Relevant articles and documents

Synthesis, Crystal Structure, and Characterization of (Z) -2-(3-chlorophenyl)- N -hydroxyacetamidine

The compound (Z)-2-(3-chlorophenyl)-N-hydroxyacetamidine, (2) was synthesized and characterized by 1H NMR, FT-IR, TGA, UV-Visible Spectra, and elemental analysis. Its molecular structure was solved by single-crystal X-ray diffraction method. Th

Novel benzimidazole-oxadiazole hybrid molecules as promising antimicrobial agents

In the present study, we describe the design and expeditious synthesis of novel 2-aryl-5-(3-aryl-[1,2,4]-oxadiazol-5-yl)-1-methyl-1H-benzo[d]imidazole hybrid molecules as promising antimicrobial agents. The core moiety 2-aryl-ethyl-1H-benzo[d]imidazole-5-

OXADIAZOLE COMPOUNDS

The present invention relates to a compound of formula (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein R1,R2,R3,L1,L2,L3,L4,L5 and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.